New Era of Healthcare Litigation: How Loper Bright Enterprises v. Raimondo Could Reshape Regulatory Behavior in the Industry

In this episode, AGG Healthcare Litigation co-chair Jason Bring and partner Brian Stimson continue their discussion on agency deference in the aftermath of the Supreme Court’s opinion in Loper Bright Enterprises, Inc. v. Raimondo, which overruled Chevron deference. The ruling has significant implications for healthcare litigation and impact agency behavior going forward.

The discussion focuses on the implications of the Supreme Court’s decision in Loper Bright Enterprises, Inc. v. Raimondo for healthcare litigation. Jason and Brian explore the potential impact on future cases involving regulatory agencies and how this change in deference could influence the outcomes of disputes in the healthcare industry. They also discuss how the Supreme Court seems to be signaling a return of authority from the Executive Branch to the courts and legislature.

Furthermore, the conversation delves into the broader implications of the Supreme Court’s decision on agency behavior moving forward. Jason and Brian analyze how this shift in deference might prompt agencies to reconsider their approach to regulatory enforcement and decision-making processes. Overall, it highlights evolving dynamics of agency deference in legal landscape and its potential ramifications for healthcare litigation and regulatory oversight while reflecting on larger trends of power distribution among branches of government and legal interpretation and enforcement.